Thrombin generation in factor VIII-depleted neonatal plasma: Nearly normal because of physiologically low antithrombin and tissue factor pathway inhibitor

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 5, 2006, Pages 1071-1077

  Fritsch, P ^a   Cvirn, G ^a,b   Cimenti, C ^a   Baier, K ^a   Gallistl, S ^a   Koestenberger, M ^a   Roschitz, B ^a   Leschnik, B ^a   Muntean, Wolfgang E ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Antithrombin; Hemophilia; Newborn; Thrombin generation; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; ARTICLE; BIOCHEMISTRY; BLEEDING; CONTROLLED STUDY; HEMOPHILIA; HEMOSTASIS; HUMAN; INCUBATION TIME; NEWBORN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION;

ADULT; ANTITHROMBINS; FACTOR VIII; HUMANS; INFANT, NEWBORN; LIPOPROTEINS; PLASMA; THROMBIN;

EID: 33645639352     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01947.x     Document Type: Article

References (27)

1. Kulkarni R, Lusher JM, Henry RC, Kallen DJ. Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: A survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's medical and scientific advisory council. Haemophilia 1999; 5: 410-15.
2. Ljung R, Lindgren AC, Petrini P, Tengborn L. Normal vaginal delivery is to be recommended for haemophilia carrier gravidae. Acta Paediatr 1994; 83: 609-11.
3. Muntean W, Belohradsky BH, Klose HJ, Riegel K. Factor VIII activity and factor VIII associated antigen in newborns. Klin Padiatr 1977; 189: 412-3 (in German).
4. Chalmers EA. Hemophilia and the newborn. Blood Rev 2004; 18: 85-92.
5. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P. Development of the human coagulation system in the fullterm infant. Blood 1987; 70: 165-72.
6. Cvirn G, Gallistl S, Muntean W. Effects of antithrombin and protein C on thrombin generation in newborn and adult plasma. Thromb Res 1999; 93: 183-90.
7. Cvirn G, Gallistl S, Leschnik B, Muntean W. Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost 2003; 1: 263-8.
8. Baier K, Cvirn G, Fritsch P, Koestenberger M, Gallistl S, Leschnik B, Muntean W. Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma. Pediatr Res 2005; 57: 685-9.
9. Vianello F, Belvini D, Dal Bello F, Tagariello G, Zanon E, Lombardi AM, Zerbinati P, Girolami A. Mild bleeding diathesis in a boy with combined severe hemophilia B and heterozygous factor V Leiden. Haemophilia 2001; 7: 511-4.
10. Lee DH, Walker IR, Teitel J, Poon MC, Ritchie B, Akabutu J, Sinclair GD, Pai M, Wu JW, Reddy S, Carter C, Growe G, Lillicrap D, Lam M, Blajchman MA. Effect of the factor V Leiden mutation on the clinical expression of severe haemophilia A. Thromb Haemost 2000; 83: 387-91.
11. Escuriola Ettingshausen C, Halimeh S, Kurnik K, Schobess R, Wermes C, Junker R, Kreuz W, Pollmann H, Nowak-Gottl U. Symptomatic onset of severe haemophilia A in childhood is dependent on the presence of prothrombotic risk factors. Thromb Haemost 2001; 85: 218-20.
12. Negrier C, Berruyer M, Durin A, Philippe N, Dechavanne M. Increased thrombin generation in a child with a combined factor IX and protein C deficiency. Blood 1993; 81: 690-695.
13. van 't Veer C, Golden NJ, Kalafatis M, Simioni P, Bertina RM, Mann KG. An in vitro analysis of the combination of haemophilia and factor V (Leiden). Blood 1997; 90: 3067-77.
14. Dargaud Y, Béguin S, Lienhart A, Al Dieri R, Trzeciak C, Bordet JC, Hemker HC, Negrier C. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost 2005; 93: 475-80.
15. Dahm A, van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandet PM. Low levels of tissue factor pathway inhibitor in patients with venous thrombosis. J Thromb Haemost 2003; 1: 507-10.
16. Dargaud Y, Cruchaudet BB, Lienhart A, Coppere B, Ninet J, Negrier C. Spontaneous proximal deep vein thrombosis in a patient with severe haemophilia A. Blood Coagul Fibrinolysis 2003; 14: 407-9.
17. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: Initiation, maintenance and regulation. Biochemistry 1991; 30: 10363-70.
18. Butenas S van 't Veer C Mann KG. 'Normal' thrombin generation. Blood 1999; 94: 2169-78.
19. Hemker HC, Wielders S, Kessels H, Beguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-24.
20. Rijkers DT, Wielders SJ, Beguin S, Hemker HC. Prevention of the influence of fibrin and alpha 2-macroglobulin in the continuous measurement of the thrombin potential: Implications for an endpoint determination of the optical density. Thromb Res 1998; 89: 161-9.
21. Wielders S, Mukherjee M, Michiels J, Rijkers DT, Cambus JP, Knebel RW, Kakkar V, Hemker HC, Beguin S. The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulability. Thromb Haemost 1997; 77: 629-36.
22. Hemker HC, Willems GM, Beguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986; 56: 9-17.
23. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
24. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S. The calibrated automated thrombogram (CAT): A universial routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002; 32: 249-53.
25. van 't Veer C, Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin III and heparin cofactor II. J Biol Chem 1997; 272: 4367-77.
26. Tay SP, Cheong SK, Boo NY. Circulating tissue factor pathway inhibitor and d-dimer in umbilical cord blood of normal term neonates and adult plasma. Blood Coagul Fibrinolysis 2003; 14: 125-9.
27. Dahm A, Andersen TO, Rosendaal F, Sandet PM. A novel activity assay of tissue factor pathway inhibitor I (TFPI). J Thromb Haemost 2005; 3: 651-8.